Literature DB >> 11427409

Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

P De Paoli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11427409      PMCID： PMC96125          DOI： 10.1128/CDLI.8.4.671-677.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  70 in total

1.  Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection.

Authors:  A E Sousa; A F Chaves; M Doroana; F Antunes; R M Victorino
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

2.  Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

Authors:  B F Haynes; L P Hale; K J Weinhold; D D Patel; H X Liao; P B Bressler; D M Jones; J F Demarest; K Gebhard-Mitchell; A T Haase; J A Bartlett
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

3.  Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.

Authors:  M Nokta; R Rossero; J Nichols; M Rosenbaum; R B Pollard
Journal:  AIDS Res Hum Retroviruses       Date:  1999-02-10       Impact factor: 2.205

Review 4.  Chemokines and HIV-1 second receptors. Confluence of two fields generates optimism in AIDS research.

Authors:  M P D'Souza; V A Harden
Journal:  Nat Med       Date:  1996-12       Impact factor: 53.440

5.  Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.

Authors:  J Blanco; C Cabrera; A Jou; L Ruiz; B Clotet; J A Esté
Journal:  AIDS       Date:  1999-04-01       Impact factor: 4.177

6.  Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with </=250/microL CD4 T cells and undetectable plasma virus load.

Authors:  A Arnó; L Ruiz; M Juan; A Jou; M Balagué; M K Zayat; S Marfil; J Martínez-Picado; M A Martínez; J Romeu; R Pujol-Borrell; C Lane; B Clotet
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

7.  IL-2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture-induced down-modulation of Bcl-2.

Authors:  Y Adachi; N Oyaizu; S Than; T W McCloskey; S Pahwa
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

8.  Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancer.

Authors:  A Franzke; D Peest; M Probst-Kepper; J Buer; G I Kirchner; G Brabant; H Kirchner; A Ganser; J Atzpodien
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

9.  Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection.

Authors:  J Borvak; C S Chou; K Bell; G Van Dyke; H Zola; O Ramilo; E S Vitetta
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry.

Authors:  L J Picker; M K Singh; Z Zdraveski; J R Treer; S L Waldrop; P R Bergstresser; V C Maino
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113
View more
  4 in total

1.  Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.

Authors:  Julie Patterson; Renee Jesser; Adriana Weinberg
Journal:  Virology       Date:  2008-06-24       Impact factor: 3.616

2.  CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV.

Authors:  Dorothy E Lewis; Kimber L Gross; Martine M Diez; Maria L Martinez; Helen N Lukefahr; Claudia A Kozinetz; Roberto C Arduino
Journal:  J Transl Med       Date:  2007-01-30       Impact factor: 5.531

Review 3.  Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System.

Authors:  Xiaorong Peng; Jing Ouyang; Stéphane Isnard; John Lin; Brandon Fombuena; Biao Zhu; Jean-Pierre Routy
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

4.  Low-dose interleukin-2 alleviates dextran sodium sulfate-induced colitis in mice by recovering intestinal integrity and inhibiting AKT-dependent pathways.

Authors:  Hana Lee; Ye Seul Son; Mi-Ok Lee; Jea-Woon Ryu; Kunhyang Park; Ohman Kwon; Kwang Bo Jung; Kwangho Kim; Tae Young Ryu; Aruem Baek; Janghwan Kim; Cho-Rok Jung; Choong-Min Ryu; Young-Jun Park; Tae-Su Han; Dae-Soo Kim; Hyun-Soo Cho; Mi-Young Son
Journal:  Theranostics       Date:  2020-04-06       Impact factor: 11.556
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.